New Therapeutic Strategy and Innovative Lubricating Ophthalmic Solution in Minimizing Dry Eye Disease Associated with Cataract Surgery: A Randomized, Prospective Study.

ABSTRACT:

Introduction

To evaluate the effects of a new lubricating, antioxidant solution (VisuEvo^®) on dry eye disease (DED) in patients undergoing cataract surgery.

Methods

Patients requiring cataract surgery with either healthy ocular surface or mild DED (tear break-up time, TBUT > 7, Schirmer I test > 15 mm/5 min) were enrolled in this multicenter, open-label, randomized, prospective study. Scheduled visits were 2 weeks before surgery (screening), day of surgery (V0), week 1 (V1), and 2 (V2) after surgery. VisuEvo^® was self-administered three times daily for the whole study duration (group A); the control group (group B) had no tear substitute administration. The primary endpoint was the change in TBUT over time; the secondary endpoints were changes in Ocular

SUBMITTER: Fogagnolo P 

PROVIDER: S-EPMC7140734 | biostudies-literature | 2020 Apr

REPOSITORIES: biostudies-literature